Production (Stage)
Compass Therapeutics, Inc.
CMPX
$2.37
-$0.04-1.66%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -54.19% | -12.06% | -5.17% | -15.94% | -37.64% |
| Total Depreciation and Amortization | -21.38% | -23.29% | -0.21% | -1.89% | -3.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 56.12% | 149.75% | 128.84% | 135.08% | 141.39% |
| Change in Net Operating Assets | 110.04% | 1,917.44% | -208.04% | 376.29% | 6.42% |
| Cash from Operations | 4.90% | 25.84% | -86.61% | -6.34% | -13.57% |
| Capital Expenditure | -- | 100.00% | -340.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 383.14% | 143.08% | 70.36% | 1,088.26% | -196.02% |
| Cash from Investing | 382.70% | 143.43% | 70.20% | 1,071.96% | -196.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -100.00% | 44,078.05% |
| Repurchase of Common Stock | -499.26% | 39.62% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | 101.05% | -- |
| Cash from Financing | -104.68% | 40.51% | -109.52% | -99.97% | 42,419.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -339.53% | 198.64% | 61.15% | 44.90% | 93.00% |